- Global Pharma News & Resources

Bausch Health Announces Participation In Upcoming Investor Conferences

Bausch Health Announces Participation In Upcoming Investor Conferences

PR Newswire

LAVAL, Quebec, Sept. 24, 2018

LAVAL, Quebec, Sept. 24, 2018 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the company will participate in two investor conferences in October.

Joseph C. Papa, chairman and chief executive officer, and Sam Eldessouky, senior vice president and corporate controller, are scheduled to participate at the Cantor Fitzgerald Global Healthcare Conference in New York on Oct. 1, 2018 at 3:30 p.m. EDT.

Paul S. Herendeen, executive vice president and chief financial officer, William Woodfield, vice president and treasurer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Deutsche Bank 26th Annual Leveraged Finance Conference in Scottsdale, Ariz. on Oct. 2, 2018 at 10:40 a.m. MST (1:40 p.m. EDT).

Live webcasts and audio archives of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at:

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at

Investor Contact:

Media Contact:

Arthur Shannon  

Lainie Keller

(514) 856-3855   

(908) 927-0617

(877) 281-6642 (toll free)     



View original content to download multimedia:

SOURCE Bausch Health Companies Inc.

Editor Details

Last Updated: 24-Sep-2018